门脉性肝硬化

目的探讨彩色多普勒（CDFI）对布-加氏综合症（Budd-Chiarisyndrome）和门脉性肝硬化的鉴别诊断。

Objective To discuss the differential diagnosis of Budd-chiari syndrome and portal cirrhosis with CD-FI .

245例门脉性肝硬化的预后（长期随访观察）

Prognosis of Portal Cirrhosis ( Long Term Follow-up of 245 cases )

彩色多普勒超声对布&加氏综合征和门脉性肝硬化的鉴别诊断探讨

Discussion on Differential Diagnosis of Budd-Chiari Syndrome and Portal Cirrhosis with CDFI

门脉性肝硬化的形态机制

The Door Morphogenesis of Portal Cirrhosis of Liver On Mechanisms

新凝灵与垂体后叶素治疗门脉性肝硬化并发上消化道出血的疗效比较

Comparison of Therapeutic Effects between Ethylenediamine Diaceturate and Pituitrin on Upper Digestive Tract Hemorrhage Resulting from Portal Cirrhosis of Liver

结论应用新凝灵静滴治疗门脉性肝硬化并发上消化道出血，在止血效果、输血量、住院天数、大便潜血转阴等方面，明显优于垂体后叶素。

Conclusion It is more helpful to apply ethylenediamine diaceturate to upper digestive tract hemorrhage resulting from portal cirrhosis of liver than pituitrin .